Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 5/20 | 0.79 |
| ▸ | SCN2A | Q99250 | 5/20 | 0.79 |
| ▸ | SCN3A | Q9NY46 | 5/20 | 0.79 |
| ▸ | LMNA | P02545 | 4/20 | 0.79 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.79 |
| ▸ | MAOA | P21397 | 3/20 | 0.79 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.79 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.79 |
| ▸ | DRD3 | P35462 | 2/20 | 0.79 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.79 |
| ▸ | CNR1 | P21554 | 1/20 | 0.79 |
| ▸ | DRD4 | P21917 | 1/20 | 0.79 |
| ▸ | ACHE | P22303 | 1/20 | 0.79 |
| ▸ | HRH2 | P25021 | 1/20 | 0.79 |
| ▸ | HTR2A | P28223 | 1/20 | 0.79 |
| ▸ | HTR2C | P28335 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.79 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Butylaminobenzoyldiethylaminoethyl SCHEMBL503018 | 0.99 | LMNA (0.79) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| Tetracaine SCHEMBL1429149 | 0.90 | LMNA (0.79) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| Tetracaine SCHEMBL34714 | 0.88 | LMNA (1.00) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| Tetracaine SCHEMBL27896875 | 0.87 | LMNA (0.97) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| Tetracaine SCHEMBL24370 | 0.87 | LMNA (1.00) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| Tetracaine SCHEMBL3176478 | 0.87 | LMNA (0.97) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| Tetracaine SCHEMBL1355595 | 0.87 | LMNA (1.00) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| Tetracaine SCHEMBL28641231 | 0.87 | LMNA (0.97) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| Tetracaine SCHEMBL7774179 | 0.87 | LMNA (0.97) | SCN1ASCN2ASCN3ALMNAHRH3 | |
| SCHEMBL29143435 | 0.86 | LMNA (0.77) | SCN1ASCN2ASCN3ALMNAHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083666-A1 | METHOD OF TREATING DISEASE | CREWS THOMAS M (US) | 2026-03-26 | — | — | US | claimed |
| US-12329856-B2 | Crosslinked hyaluronic acid composition with local anesthetics | BIOPOLIMERI S.R.L. (IT) | 2025-06-17 | — | — | US | claimed |
| EP-4362994-B1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | BIOPOLIMERI S R L (IT) | 2025-03-12 | — | — | EP | claimed |
| US-20240293311-A1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | BIOPOLIMERI S.R.L. (IT) | 2024-09-05 | — | — | US | claimed |
| EP-4362994-A1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | Biopolimeri S.r.l. (IT) | 2024-05-08 | — | — | EP | claimed |
| WO-2023003384-A1 | POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME | 주식회사 삼양홀딩스 | 2023-01-26 | — | — | WO | claimed |
| WO-2023275241-A1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | BIOPOLIMERI S.R.L. (IT) | 2023-01-05 | — | — | WO | claimed |
| US-20220387307-A1 | METHOD OF TREATING DISEASE | CREWS THOMAS M (US) | 2022-12-08 | — | — | US | claimed |
| WO-2022149924-A1 | CROSSLINKED HYALURONIC ACID HYDROGEL CROSSLINKED USING CROSSLINKER AND POLYOL, AND FILLER COMPRISING SAME | 주식회사 엘지화학 | 2022-07-14 | — | — | WO | claimed |
| US-8956160-B2 | Device and method for delivering an oral care agent | RANIR, LLC (US) | 2015-02-17 | — | — | US | claimed |
| US-20060240037-A1 | Methods and compositions for the treatment and prevention of degenerative joint disorders | MUCOSAL THERAPEUTICS LLC | 2006-10-26 | — | — | US | claimed |
| US-20060189526-A1 | COMPOSITIONS CONTAINING AN INTESTINAL TREFOIL PEPTIDE AND A MUCOADHESIVE | THE GENERAL HOSPITAL CORPORATION | 2006-08-24 | — | — | US | claimed |
| US-20060188471-A1 | METHODS OF TREATING EPITHELIAL LESIONS | THE GENERAL HOSPITAL CORPORATION | 2006-08-24 | — | — | US | claimed |
| EP-1575951-A1 | HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY | Affinium Pharmaceuticals, Inc. (CA) | 2005-09-21 | — | — | EP | claimed |
| WO-2005000331-A2 | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF DEGENERATIVE JOINT DISORDERS | MUCOSAL THERAPEUTICS, INC. (US) | 2005-01-06 | — | — | WO | claimed |
| WO-2004052890-A1 | HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY | AFFINIUM PHARMACEUTICALS, INC. (CA) | 2004-06-24 | — | — | WO | claimed |
| US-20040005277-A1 | Device and method for delivering an oral care agent | JPMORGAN CHASE BANK, N.A. | 2004-01-08 | — | — | US | claimed |
| US-20030175360-A1 | Symptomatic relief of gastrointestinal disorders | LUZZATTI RENZO (US) | 2003-09-18 | — | — | US | claimed |
| WO-2003072048-A2 | SYMPTOMATIC RELIEF OF GASTROINTESTINAL DISORDERS | PAOLO RENZO LUZZATTI (US) | 2003-09-04 | — | — | WO | claimed |
| US-4105760-A | Local anaesthetic salts of chondroitinsulfate compounds | SZEJTLI JOZSEF | 1978-08-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12329856-B2 | Crosslinked hyaluronic acid composition with local anesthetics | CD44, HCAR3, HCAR2 | SCN1A 2618/4885SCN2A 2486/4885SCN3A 2849/4885 |
| US-20260083666-A1 | METHOD OF TREATING DISEASE | RYR2, RYR1, OPRL1 | SCN1A 842/4885SCN2A 904/4885SCN3A 665/4885 |
| US-20220387307-A1 | METHOD OF TREATING DISEASE | COXFA4L2, ASAH2, OTC | SCN1A 1405/4885SCN2A 2081/4885SCN3A 1010/4885 |
| US-20240293311-A1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | CD44, HCAR3, HCAR2 | SCN1A 2618/4885SCN2A 2486/4885SCN3A 2849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.